UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes

BMC infectious diseases, 2013-01, Vol.13 (1), p.29-29, Article 29

2013

Volltextzugriff (PDF)

Application of the 2008 Definitions for Invasive Fungal Diseases to the Trial Comparing Voriconazole Versus Amphotericin B for Therapy of Invasive Aspergillosis: A Collaborative Study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group

Clinical infectious diseases, 2015-03, Vol.60 (5), p.713-720

2015

Volltextzugriff (PDF)

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation

British journal of haematology, 2011-11, Vol.155 (3), p.318-327

2011

Volltextzugriff (PDF)

Voriconazole Treatment for Less-Common, Emerging, or Refractory Fungal Infections

Clinical infectious diseases, 2003-05, Vol.36 (9), p.1122-1131

2003

Volltextzugriff (PDF)

Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign

Clinical infectious diseases, 2007-02, Vol.44 (3), p.373-379

2007

Volltextzugriff (PDF)

Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis

Journal of Clinical Microbiology, 2012-07, Vol.50 (7), p.2330-2336

2012

Volltextzugriff (PDF)

Early Proinflammatory Cytokines and C-Reactive Protein Trends as Predictors of Outcome in Invasive Aspergillosis

The Journal of infectious diseases, 2010-11, Vol.202 (9), p.1454-1462

2010

Volltextzugriff (PDF)

Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients

The American journal of tropical medicine and hygiene, 2007-08, Vol.77 (2), p.350-353

2007

Volltextzugriff (PDF)

An Open-Label Comparative Pilot Study of Oral Voriconazole and Itraconazole for Long-Term Treatment of Paracoccidioidomycosis

Clinical infectious diseases, 2007-12, Vol.45 (11), p.1462-1469

2007

Volltextzugriff (PDF)

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome

BMC infectious diseases, 2011-09, Vol.11 (1), p.261-261, Article 261

2011

Volltextzugriff (PDF)

Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis

PloS one, 2014-02, Vol.9 (2), p.e90176

2014

Volltextzugriff (PDF)

Review of the basic and clinical pharmacology of sulfobutylether-β-cyclodextrin (SBECD)

Journal of pharmaceutical sciences, 2010-08, Vol.99 (8), p.3291-3301

2010

Volltextzugriff (PDF)

Fosmanogepix Therapy of Disseminated Fusarium Infection

Clinical infectious diseases, 2023-09, Vol.77 (6), p.848-850

2023

Volltextzugriff (PDF)

Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host

Clinical infectious diseases, 2024-08, Vol.79 (2), p.572-572

2024

Volltextzugriff (PDF)

Combination antifungal therapy for invasive aspergillosis: a randomized trial

Annals of internal medicine, 2015-01, Vol.162 (2), p.81-89

2015

Volltextzugriff (PDF)

Strategy of Following Voriconazole versus Amphotericin B Therapy with Other Licensed Antifungal Therapy for Primary Treatment of Invasive Aspergillosis: Impact of Other Therapies on Outcome

Clinical infectious diseases, 2005-11, Vol.41 (10), p.1448-1452

2005

Volltextzugriff (PDF)

Ocular Manifestations of Candidemia

Clinical infectious diseases, 2011-08, Vol.53 (3), p.262-268

2011

Volltextzugriff (PDF)

Changes in causes of death over time after treatment for invasive aspergillosis

Cancer, 2008-05, Vol.112 (10), p.2309-2312

2008

Volltextzugriff (PDF)

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis

Critical care (London, England), 2011-01, Vol.15 (5), p.R253-R253, Article R253

2011

Volltextzugriff (PDF)

Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis

American journal of health-system pharmacy, 2007-12, Vol.64 (24), p.2561-2568

2007

Volltextzugriff (PDF)

An open-label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America

Mycoses, 2014-01, Vol.57 (1), p.12-18

2014

Volltextzugriff (PDF)

An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity

Journal of antimicrobial chemotherapy, 2013-07, Vol.68 (7), p.1655-1659

2013

Volltextzugriff (PDF)

Tissue Distribution of Anidulafungin in Neonatal Rats

Birth defects research. Part B. Developmental and reproductive toxicology, 2012-02, Vol.95 (1), p.89-94

2012

Volltextzugriff (PDF)

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

The New England journal of medicine, 2002-08, Vol.347 (6), p.408-415

2002

Volltextzugriff (PDF)

Combination Therapy for Invasive Aspergillosis: Controversies and Conclusions

Current fungal infection reports, 2015-06, Vol.9 (2), p.130-134

2015

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

Humans
(35)
Science & Technology
(34)
Life Sciences & Biomedicine
(33)
Female
(23)
Infectious Diseases
(23)
Male
(23)
Antifungal Agents - Therapeutic Use
(20)
Middle Aged
(19)
Adult
(17)
Biological And Medical Sciences
(16)
Voriconazole
(16)
Medical Sciences
(15)
Microbiology
(15)
Aged
(14)
Treatment Outcome
(14)
Aspergillosis - Drug Therapy
(12)
Immunology
(11)
Pyrimidines - Therapeutic Use
(11)
Triazoles - Therapeutic Use
(11)
Antifungal Agents - Administration & Dosage
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation

Voriconazole Treatment for Less-Common, Emerging, or Refractory Fungal Infections

Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign

Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis

Early Proinflammatory Cytokines and C-Reactive Protein Trends as Predictors of Outcome in Invasive Aspergillosis

Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients

An Open-Label Comparative Pilot Study of Oral Voriconazole and Itraconazole for Long-Term Treatment of Paracoccidioidomycosis

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome

Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis

Review of the basic and clinical pharmacology of sulfobutylether-β-cyclodextrin (SBECD)

Fosmanogepix Therapy of Disseminated Fusarium Infection

Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host

Combination antifungal therapy for invasive aspergillosis: a randomized trial

Strategy of Following Voriconazole versus Amphotericin B Therapy with Other Licensed Antifungal Therapy for Primary Treatment of Invasive Aspergillosis: Impact of Other Therapies on Outcome

Ocular Manifestations of Candidemia

Changes in causes of death over time after treatment for invasive aspergillosis

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis

Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis

An open-label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America

An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity

Tissue Distribution of Anidulafungin in Neonatal Rats

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Combination Therapy for Invasive Aspergillosis: Controversies and Conclusions

Suchergebnisse filtern